Ifosfamide-based chemotherapy for recurrent or metastatic hemangiopericytoma.
Celik
I
I
Hacettepe University Institute of Oncology, Department of Medical Oncology, Ankara, Turkiye.
Başçil
N
N
Yalçin
S
S
Güllü
I H
IH
Kars
A
A
Barişta
I
I
Tekuzman
G
G
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005542:Forearm; D006393:Hemangiopericytoma / Q000188:drug therapy* / Q000556:secondary; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D016879:Salvage Therapy; D013899:Thoracic Neoplasms / Q000188:drug therapy*
D005047:Etoposide; D015080:Mesna; D007069:Ifosfamide